DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epivir-HBV (Lamivudine) - Current Clinical Trials

 
 



Epivir-HBV Related Clinical Trials

Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa [Completed]

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load [Active, not recruiting]

Comparison Between Lamivudine and Entecavir Treatment in Patients [Recruiting]

To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir [Completed]

Estimate The Effect Of Lersivirine On The Pharmacokinetics Of Abacavir/Lamivudine In Healthy Subjects [Completed]

Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection [Not yet recruiting]

Lamivudine and Adefovir Dipivoxil Fixed Dose Combination [Completed]

Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients [Recruiting]

Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL [Recruiting]

Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA [Completed]

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA [Completed]

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA [Completed]

Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir [Completed]

Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject [Active, not recruiting]

A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult Subjects [Active, not recruiting]

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults [Completed]

Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) [Completed]

Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study [Recruiting]

Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression [Active, not recruiting]

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children [Completed]

Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients [Terminated]

First-Line Treatment for HIV-2 [Not yet recruiting]

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy [Completed]

Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz [Completed]

Evaluation of a Maintenance Strategy With Protease Inhibitors With or Without Lamivudine in Virologically Suppressed HIV Patients on Second Line Antiretroviral Treatment in Africa [Recruiting]

Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand [Completed]

Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B [Completed]

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) [Completed]

Bioequivalence Study of Pediatric Formulations to Treat HIV Infection [Active, not recruiting]

TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA [Enrolling by invitation]

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV [Completed]

Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children [Completed]

A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen [Active, not recruiting]

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV [Completed]

A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir«) and Dolutegravir (Tivicay«) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol) [Not yet recruiting]

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B [Completed]

A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA) [Active, not recruiting]

Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy [Terminated]

Lamivudine and Adefovir to Treat Chronic Hepatitis B [Completed]

Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2) [Terminated]

Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma [Not yet recruiting]

Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. [Completed]

Dolutegravir-Lamivudine as Dual Therapy in Naive HIV-Infected Patients: A Pilot Study [Active, not recruiting]

Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis B [Withdrawn]

Safety & Efficacy of Dual Therapy With Raltegravir/Lamivudine [Not yet recruiting]

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal [Completed]

Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis [Completed]

Switch Study to Evaluate F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed on Regimens Containing ABC/3TC [Recruiting]

Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding [Completed]

Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine [Recruiting]

Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis) [Completed]

Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive [Not yet recruiting]

Abacavir and Lamivudine PK in Children [Completed]

Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients [Active, not recruiting]

Multicentric Open-label Study of Switch From Abacavir/Lamivudine Fixed Dose Combination Plus Nevirapine to Abacavir/Lamivudine/Dolutegravir in Virologically Suppressed HIV-1 Infected Adults (SWAD) [Active, not recruiting]

Efficacy Optimizing Research of Lamivudine Therapy [Completed]

Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects [Completed]

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) [Active, not recruiting]

Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B [Recruiting]

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus [Completed]

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks [Completed]

SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and Over [Recruiting]

Lamivudine for Chronic Hepatitis B [Completed]

Triomune Bioequivalence With Innovators [Completed]

Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily [Completed]

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects. [Completed]

Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents [Recruiting]

Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284) [Recruiting]

Study of Options for Second-Line Effective Combination Therapy (SELECT) [Active, not recruiting]

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT) [Recruiting]

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects [Active, not recruiting]

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection [Completed]

A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy [Recruiting]

The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens [Completed]

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission [Completed]

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV [Completed]

Lactic Acidosis During Entecavir(ETV)Treatment [Terminated]

Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection [Completed]

A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection [Completed]

Safety and Efficacy of Raltegravir+TDF+3TC in HBV/HIV Co-infected Patients [Not yet recruiting]

Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine [Terminated]

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection [Terminated]

Resistance to Lamivudine in HBV Egyptian Patients [Completed]

Zidovudine and Lamivudine Given Once Versus Twice Daily [Completed]

Replacement of Lamivudine by Telbivudine to Improve Renal Function [Enrolling by invitation]

Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV Drugs [Completed]

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen [Completed]

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC [Completed]

A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children [Completed]

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients [Recruiting]

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine [Completed]

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine [Completed]

ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017